Comments on: AstraZeneca shares slip despite new Japan orphan drug designation https://ukinvestor.foxrobinson.com/astrazeneca-shares-slip-despite-new-japan-orphan-drug-designation/ Tue, 01 Sep 2020 06:53:40 +0000 hourly 1 https://wordpress.org/?v=6.6.3 By: AstraZeneca receives EU approval for new lung cancer treatment - UK Investor Magazine https://ukinvestor.foxrobinson.com/astrazeneca-shares-slip-despite-new-japan-orphan-drug-designation/#comment-15849 Tue, 01 Sep 2020 06:53:40 +0000 https://ukinvestor.foxrobinson.com/?p=29744#comment-15849 […] pharmaceutical firm AstraZeneca (LON:AZN) has announced the EU approval of Imfinzi as a first-line treatment for adults suffering […]

]]>